Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Interest Expenses (2022 - 2025)

Historic Interest Expenses for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$16786.5.

  • InflaRx's Interest Expenses fell 20375.91% to -$16786.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29989.0, marking a year-over-year increase of 2798.72%. This contributed to the annual value of -$22355.7 for FY2024, which is 4168.12% up from last year.
  • InflaRx's Interest Expenses amounted to -$16786.5 in Q3 2025, which was down 20375.91% from -$3797.7 recorded in Q2 2025.
  • InflaRx's 5-year Interest Expenses high stood at -$3797.7 for Q2 2025, and its period low was -$6.9 billion during Q3 2022.
  • Over the past 4 years, InflaRx's median Interest Expenses value was -$5992.9 (recorded in 2022), while the average stood at -$855.7 million.
  • Data for InflaRx's Interest Expenses shows a peak YoY increase of 9999.99% (in 2023) and a maximum YoY decrease of 2150268308.95% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows InflaRx's Interest Expenses stood at -$5992.9 in 2022, then tumbled by 261.8% to -$21682.3 in 2023, then soared by 76.45% to -$5106.8 in 2024, then tumbled by 228.71% to -$16786.5 in 2025.
  • Its last three reported values are -$16786.5 in Q3 2025, -$3797.7 for Q2 2025, and -$4298.0 during Q1 2025.